Test Description

What are Platelets?

Platelets (thrombocytes) are small, disc-shaped cell fragments derived from megakaryocytes in the bone marrow. They are essential for hemostasis (stopping bleeding) by forming platelet plugs at sites of vascular injury and providing a surface for blood clotting.

Platelet Function and Lifespan

  • Lifespan: 7-10 days in circulation
  • Production: Produced from megakaryocytes in bone marrow; regulated by thrombopoietin (TPO)
  • Primary hemostasis: Platelets adhere to damaged vessel walls, activate, and aggregate to form platelet plug
  • Secondary hemostasis: Provide phospholipid surface for coagulation cascade (fibrin clot formation)
  • Destruction: Removed by spleen and liver after 7-10 days or after activation

How Platelets Work in Hemostasis

When blood vessels are injured, platelets respond through a series of steps:

  • Adhesion: Platelets stick to exposed collagen via von Willebrand factor (vWF)
  • Activation: Activated platelets change shape, release granule contents (ADP, serotonin, thromboxane A2)
  • Aggregation: Released factors recruit more platelets, forming platelet plug
  • Clot stabilization: Fibrin mesh reinforces platelet plug to form stable clot

Why is Platelet Count Important?

Platelet count provides critical information for clinical decision-making:

  • Bleeding risk assessment: Low platelets increase bleeding risk, especially with procedures or trauma
  • Transfusion guidance: Determines need for platelet transfusion before surgery or in bleeding patients
  • Medication monitoring: Many medications cause thrombocytopenia (heparin, chemotherapy, antibiotics)
  • Clotting disorder screening: Detects ITP, TTP, HUS, DIC, and hematologic malignancies
Platelet Count vs. Platelet Function: Normal platelet count doesn't guarantee normal hemostasis. Some patients with normal counts have defective platelet function (e.g., aspirin use, von Willebrand disease, uremia). Conversely, patients with mild thrombocytopenia (50,000-100,000/μL) rarely bleed spontaneously if platelets function normally.
Quick Reference
  • Normal Range: 150,000-450,000/μL (or 150-450 × 10⁹/L)
  • Critical Low: <10,000/μL (spontaneous bleeding risk)
  • Critical High: >1,000,000/μL (thrombosis and paradoxical bleeding risk)
  • Thrombocytopenia: <150,000/μL (low platelets)
  • Thrombocytosis: >450,000/μL (high platelets)
  • Primary Use: Assess bleeding risk, guide platelet transfusion, diagnose hematologic disorders
  • Sample Type: Whole blood (EDTA tube - purple top)
  • Key Point: Bleeding risk correlates with platelet count; spontaneous bleeding rare above 10,000-20,000/μL
Normal Ranges

Platelet counts are relatively consistent across age and sex, though pregnant women and newborns may have slightly different ranges.

Swipe to see more
Population Normal Range (/μL) SI Units (× 10⁹/L)
Adults (male and female) 150,000-450,000 150-450
Pregnant Women 100,000-400,000 100-400
Newborns (0-2 weeks) 150,000-450,000 150-450
Infants and Children 150,000-450,000 150-450
Important Considerations:
  • Critical values: Platelets <10,000 or >1,000,000 should be reported immediately
  • Gestational thrombocytopenia: 5-10% of pregnant women develop mild thrombocytopenia (100,000-150,000) in third trimester; usually benign
  • Pseudothrombocytopenia: Falsely low platelet count due to EDTA-induced platelet clumping (1-2% of samples)
  • Platelet clumping: Always check peripheral smear if unexplained thrombocytopenia
  • Ethnic variations: Some populations have slightly lower baseline counts without pathology
Clinical Significance

Thrombocytopenia (Low Platelet Count <150,000/μL)

Thrombocytopenia is classified by mechanism: decreased production, increased destruction, or sequestration.

Decreased Platelet Production

  • Bone marrow failure: Aplastic anemia, myelodysplastic syndrome
  • Marrow infiltration: Leukemia, lymphoma, metastatic cancer, myelofibrosis
  • Nutritional deficiencies: Vitamin B12, folate deficiency (megaloblastic anemia affecting all cell lines)
  • Medications: Chemotherapy agents, alcohol (direct marrow toxicity)
  • Viral infections: HIV, hepatitis C, EBV (marrow suppression)

Increased Platelet Destruction

  • Immune Thrombocytopenia (ITP): Autoantibodies destroy platelets; most common cause in otherwise healthy patients
  • Drug-induced: Heparin (HIT), quinine, sulfonamides, vancomycin, valproic acid, linezolid
  • Thrombotic Thrombocytopenic Purpura (TTP): Microangiopathic hemolytic anemia with schistocytes, fever, renal failure, neurologic changes
  • Hemolytic Uremic Syndrome (HUS): Similar to TTP; often follows E. coli O157:H7 diarrhea in children
  • Disseminated Intravascular Coagulation (DIC): Consumption of platelets and clotting factors; prolonged PT/PTT, low fibrinogen, elevated D-dimer
  • Post-transfusion purpura: Rare; severe thrombocytopenia 5-10 days after transfusion

Platelet Sequestration

  • Hypersplenism: Enlarged spleen sequesters up to 90% of platelets (cirrhosis, portal hypertension, lymphoma)
  • Splenic sequestration crisis: Acute in sickle cell disease

Dilutional Thrombocytopenia

  • Massive transfusion: Transfusion of >10 units packed RBCs without platelet replacement
  • Massive fluid resuscitation: Dilutes circulating platelets

Pregnancy-Related

  • Gestational thrombocytopenia: Benign; platelets 100,000-150,000 in third trimester
  • HELLP syndrome: Hemolysis, Elevated Liver enzymes, Low Platelets; severe preeclampsia complication
  • Preeclampsia/eclampsia: Platelet activation and consumption

Thrombocytosis (High Platelet Count >450,000/μL)

Elevated platelet count is classified as primary (clonal) or secondary (reactive).

Primary (Clonal) Thrombocytosis

  • Essential thrombocythemia: Myeloproliferative neoplasm with JAK2, CALR, or MPL mutations; platelets often >600,000-1,000,000
  • Polycythemia vera: Myeloproliferative disorder with elevated RBCs, WBCs, and platelets
  • Chronic myeloid leukemia (CML): BCR-ABL positive; marked leukocytosis with thrombocytosis
  • Myelodysplastic syndromes: Especially 5q deletion syndrome

Secondary (Reactive) Thrombocytosis

  • Acute inflammation or infection: Pneumonia, UTI, inflammatory bowel disease
  • Chronic inflammatory conditions: Rheumatoid arthritis, Crohn's disease, ulcerative colitis
  • Tissue damage: Recent surgery, trauma, burns
  • Iron deficiency: Thrombocytosis common even before anemia develops
  • Malignancy: Lung, gastric, ovarian, breast cancer (paraneoplastic)
  • Post-splenectomy: Loss of splenic sequestration; can reach 600,000-1,000,000
  • Rebound thrombocytosis: After chemotherapy or severe infection recovery
  • Medications: All-trans retinoic acid (ATRA), G-CSF
Distinguishing Primary vs. Secondary Thrombocytosis: Primary (clonal) thrombocytosis is persistent, often >600,000, associated with other cytopenias or cytoses, and carries thrombosis risk. Secondary (reactive) thrombocytosis is usually <600,000, transient, improves when underlying condition treated, and rarely causes thrombosis. If platelets >600,000 or persistent elevation, refer to hematology.
Interpretation Guidelines

Bleeding Risk by Platelet Count

Swipe to see more
Platelet Count (/μL) Bleeding Risk Clinical Implications
>100,000 Minimal Safe for most procedures; no spontaneous bleeding
50,000-100,000 Mild Increased surgical bleeding; generally safe for minor procedures
20,000-50,000 Moderate Increased bleeding with trauma; bruising common; avoid major surgery
10,000-20,000 High Spontaneous mucosal bleeding (epistaxis, gingival bleeding); consider transfusion
<10,000 Severe High risk spontaneous bleeding including intracranial hemorrhage; transfuse

Platelet Transfusion Guidelines

Platelet Transfusion Thresholds:
  • Active bleeding: Transfuse if platelets <50,000/μL (some say <30,000 for minor bleeding)
  • Major surgery or invasive procedures: Target platelets >50,000/μL pre-procedure
  • Neurosurgery or ophthalmic surgery: Target platelets >100,000/μL
  • Prophylactic (no bleeding): Transfuse if <10,000/μL to prevent spontaneous bleeding
  • Minor procedures (LP, central line): Target >20,000-50,000/μL
DON'T transfuse platelets in:
  • TTP/HUS: Platelet transfusion can worsen microvascular thrombosis
  • HIT (Heparin-Induced Thrombocytopenia): Risk of thrombosis, not bleeding
  • ITP: Transfused platelets are rapidly destroyed; reserve for life-threatening bleeding

Expected Response to Platelet Transfusion

  • One unit platelets (apheresis): Raises platelet count by ~30,000-50,000/μL in average adult
  • One unit platelets (pooled): Raises count by ~5,000-10,000/μL per unit (typically 4-6 units pooled)
  • Post-transfusion check: Measure platelet count 10-60 minutes and 24 hours post-transfusion
  • Poor response: Suggests platelet refractoriness (alloimmunization, HLA antibodies, splenomegaly, DIC, sepsis)

Approach to Thrombocytopenia

Step 1: Confirm thrombocytopenia - rule out pseudothrombocytopenia by checking peripheral smear

Step 2: Assess bleeding risk and clinical urgency

Step 3: Review medication list for culprit drugs

Step 4: Categorize by mechanism:

  • Isolated thrombocytopenia (normal WBC/Hgb): ITP, drug-induced, infection
  • Pancytopenia (low WBC, RBC, platelets): Bone marrow failure, megaloblastic anemia, hypersplenism
  • Microangiopathic hemolytic anemia (schistocytes on smear): TTP, HUS, DIC, HELLP

Step 5: Order targeted testing:

  • PT/PTT, fibrinogen, D-dimer (if DIC suspected)
  • Peripheral smear (schistocytes, platelet clumping)
  • HIV, HCV (if risk factors present)
  • Consider bone marrow biopsy if unexplained or concern for malignancy
Interfering Factors

Factors That Decrease Platelets

  • Medications (most common cause): Heparin (HIT), chemotherapy, valproic acid, antibiotics (vancomycin, linezolid, sulfonamides), anticonvulsants, quinine
  • Alcohol: Direct bone marrow toxicity and splenic sequestration
  • Viral infections: HIV, hepatitis C, EBV, CMV, dengue
  • Hypothermia: Platelet sequestration and dysfunction

Factors That Increase Platelets

  • Iron deficiency: Even without anemia, iron deficiency commonly causes thrombocytosis
  • Inflammation: Acute infection, trauma, surgery, inflammatory diseases
  • Medications: All-trans retinoic acid (ATRA), G-CSF/GM-CSF, epinephrine
  • Exercise: Strenuous exercise transiently increases platelet count
  • Smoking: Chronic smokers have mildly elevated platelet counts

Pseudothrombocytopenia

  • EDTA-induced clumping: Platelets clump in EDTA tubes, causing falsely low automated count (1-2% of samples)
  • Diagnosis: Review peripheral smear showing platelet clumps; normal platelet count on smear estimation
  • Solution: Redraw in citrate tube or heparin tube; perform manual platelet count
  • Clinical significance: No clinical consequence; platelets function normally

Pre-analytical Errors

  • Clotted sample: Platelets consumed in clot; falsely low count
  • Delayed processing: Platelets degrade over time; process within 4 hours
  • Giant platelets: May be counted as small RBCs or WBCs by automated analyzers
  • Hemolysis: Can interfere with optical platelet counting
Clinical Pearls
"Spontaneous bleeding rare above 10,000-20,000/μL": Patients with platelet counts above this threshold rarely bleed spontaneously unless they have concurrent platelet dysfunction (uremia, aspirin, NSAIDs) or coagulopathy. Focus prophylactic transfusions on those <10,000/μL.
Always check peripheral smear for unexplained thrombocytopenia: Pseudothrombocytopenia (EDTA-induced clumping) occurs in 1-2% of samples. The smear will show platelet clumps and normal platelet numbers. Don't panic and transfuse based on automated count alone.
HIT (Heparin-Induced Thrombocytopenia) causes thrombosis, not bleeding: Despite low platelet count (typically 50,000-150,000), HIT causes dangerous arterial and venous thrombosis. If platelets drop >50% after starting heparin (days 5-14), stop heparin immediately, check HIT antibody, and start alternative anticoagulant (argatroban, bivalirudin). Never transfuse platelets in HIT.
Don't transfuse platelets in TTP/HUS: Thrombotic microangiopathies (TTP, HUS) involve platelet-rich microvascular thrombi. Platelet transfusion worsens microvascular thrombosis and can precipitate stroke or MI. Treatment is plasmapheresis (TTP) or supportive care (HUS), not platelets. Reserve platelet transfusion for life-threatening bleeding only.
ITP diagnosis is exclusion: Immune Thrombocytopenia (ITP) causes isolated thrombocytopenia with normal WBC, hemoglobin, and peripheral smear (except low platelets). Rule out drugs, HIV, HCV, and other causes first. Treatment: corticosteroids, IVIG, or anti-D for platelets <30,000 or bleeding.
Gestational thrombocytopenia is common and benign: 5-10% of pregnant women develop platelet counts 100,000-150,000 in third trimester. This is physiologic, not pathologic. Differentiate from HELLP, preeclampsia (hypertension, proteinuria, elevated LFTs), or ITP (platelets usually <100,000).
Iron deficiency causes thrombocytosis: Even without anemia, iron deficiency commonly elevates platelets to 500,000-700,000. This is reactive thrombocytosis and rarely causes thrombosis. Treat the iron deficiency and platelets will normalize.
Essential thrombocythemia threshold is >450,000: But most patients have counts >600,000-1,000,000. If persistent platelets >600,000 without obvious reactive cause (infection, inflammation, iron deficiency), refer to hematology for JAK2/CALR/MPL mutation testing. ET carries thrombosis risk; may need aspirin or cytoreductive therapy (hydroxyurea).
Post-splenectomy thrombocytosis peaks at 7-21 days: After splenectomy, platelet count rises (loss of splenic sequestration) and can reach 600,000-1,000,000. Usually benign and self-limited. Consider aspirin prophylaxis if >1,000,000 or thrombosis risk factors. Counts typically normalize over weeks to months.
References
  1. Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. New England Journal of Medicine, 351, 1548-1564.
  2. Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
  3. Farinde, A. (2021). Lab values, normal adult: Laboratory reference ranges in healthy adults. Medscape. https://emedicine.medscape.com/article/2172316-overview?form=fpf
  4. Nickson, C. (n.d.). Critical Care Compendium. Life in the Fast Lane • LITFL. https://litfl.com/ccc-critical-care-compendium/
  5. Farkas, Josh MD. (2015). Table of Contents - EMCrit Project. EMCrit Project. https://emcrit.org/ibcc/toc/
Back to CBC Panel All Lab Values
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.